VAV Life Sciences launches India’s first Phospholipid manufacturing plant

Most phospholipids are derived from nature, hence classified as GRAS

buildings-304004-640

One of the top phospholipid manufacturers, VAV Life Sciences inaugurated its cGMP compliant Phospholipid manufacturing plant in Mirjole, Ratnagiri, Maharashtra. The plant is set up in India considering the emerging healthcare applications of lecithins & phospholipids in functional foods, nutritional supplements, novel pharmaceuticals and cosmetics. With the plant, the company will mark products manufactured at the factory with a ‘Made in India' label and will export 80% of them to North America, Europe, Asia and ROW region. The existing brands manufactured include LECIVA, LIPOVA, OLEOVA.

The first phase of the plant is spread across 30,000 sq.ft. with EU cGMP standard facilities. The facility utilises state-of-the-art technology, which allows the production of its all-natural higher grade of phospholipids ingredient in accordance with the global industry standards.

Most phospholipids are derived from nature, hence classified as GRAS (Generally Recognised as Safe) by US FDA. Through the plant, VAV Life Sciences will be building distinct production lines for refined soya, egg and synthetic Phospholipids. Ratnagiri location was the first choice to set up this plant due to its excellent infrastructure facilities, conducive business environment, suitable weather conditions and quality trained manpower.

Highlighting the importance of Phospholipids in global markets, Arun Kedia, CMD of VAV Life Sciences Pvt Ltd. says, "Phospholipids help drugs to target specific organs, tissues or even cells in the human body thus increases efficacy and eliminates toxicity. The increasing demand for green and naturally sourced ingredients, coupled with increasing consumer awareness towards healthy lifestyle, has raised demand for phospholipids. Besides, the nascent market for phospholipids is projected to reach USD 1.1 Billion by 2020 globally."

In addition, he shares that "High acceptance, awareness, and demand for phospholipids-based products in the nutrition & health supplements industry has further triggered demand in North American and European region as well."

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email

X